Literature DB >> 1188959

Effects of tobacco and tobacco smoke constituents on cell multiplication in vitro.

A Pilotti, K Ancker, E Arrhenius, C Enzell.   

Abstract

Ascites sarcoma BP8 cells, cultured in suspension in vitro were used as a general toxicity test system for tobacco and tobacco smoke constituents. Some 250 compounds, representative of these materials, were examined by exposing cells to different concentrations of these constituents and measuring the inhibition of culture growth, which was related to corresponding effects encountered for positive standards. When employing the present cell toxicity test system possible effects of factors such as penetration, distribution and microsomal metabolism of the compounds studied, are not taken into account. The most active constituents were found to be unsaturated aldehydes and ketones, phenols and indoles. The good correlation obsered between functional groups and toxicity permits, within the range of functionalities studied, prediction of the toxicity for a compound of known structure.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1188959     DOI: 10.1016/0300-483x(75)90069-4

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  3 in total

1.  Effects of cigarette smoke components on in vitro chemotaxis of human polymorphonuclear leukocytes.

Authors:  R B Bridges; J H Kraal; L J Huang; M B Chancellor
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

2.  An evaluation of the utility of four in vitro short term tests for predicting the cytotoxicity of individual compounds derived from tobacco smoke.

Authors:  M Curvall; C R Enzell; B Pettersson
Journal:  Cell Biol Toxicol       Date:  1984-10       Impact factor: 6.691

3.  CSEO - the Cigarette Smoke Exposure Ontology.

Authors:  Erfan Younesi; Sam Ansari; Michaela Guendel; Shiva Ahmadi; Chris Coggins; Julia Hoeng; Martin Hofmann-Apitius; Manuel C Peitsch
Journal:  J Biomed Semantics       Date:  2014-07-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.